Episode
The Global Story: Will the new cancer vaccine survive RFK Jr’s America?
- Podcast
- Global News Podcast
- Published
- Aug 30, 2026
- Duration seconds
- 1666
- Processing state
not_requested- Canonical source
- http://www.bbc.co.uk/programmes/p0p6shvl
Actions
POST https://stenobird.com/v1/public/podcasts/global-news-podcast-204504/episodes/the-global-story-will-the-new-cancer-vaccine-survive-rfk-jr-s-america/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/global-news-podcast-204504/the-global-story-will-the-new-cancer-vaccine-survive-rfk-jr-s-america.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
A new personalised vaccine given in combination with a drug has stopped skin cancer returning in patients during a trial, representing a potentially watershed moment in cancer treatment. Scientists used mRNA technology, which was used for some Covid-19 vaccines. But that technology - and vaccines more generally - have become increasingly controversial in the United States since the Covid-19 pandemic. The Health Secretary Robert F Kennedy Jr, is a vaccine sceptic. In August 2025 cancelled $500m (£376m) in funding for mRNA vaccine research. The move impacted 22 projects being led by major pharmaceutical companies, including Pfizer and Moderna, for vaccines against bird flu and other viruses, according to Kennedy’s department. We speak to Tom Whipple, host of the BBC’s Inside Science programme, about the science of this new vaccine. And we ask how funding cuts for vaccine research could impact health outcomes not just for Americans, but for the world. For more episodes, just search 'The Global Story' wherever you get your BBC Podcasts.